会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD OF SENSITIZING TUMOR CELLS WITH ADENOVIRUS E1A
    • 用ADENOVIRUS E1A致敏肿瘤细胞的方法
    • WO1996007322A1
    • 1996-03-14
    • PCT/US1995011342
    • 1995-09-05
    • LA JOLLA CANCER RESEARCH FOUNDATION
    • LA JOLLA CANCER RESEARCH FOUNDATIONFRISCH, Steven, M.
    • A01N43/04
    • C07K14/005A61K38/00A61K41/0038C12N2710/10322
    • The present invention is directed to methods of sensitizing a human tumor cell with adenovirus E1A. The methods involve treating a human tumor cell by, first, introducing into the tumor cell nucleic acid encoding a polypeptide having adenovirus E1A activity, expressing the E1A active polypeptide in the cell, and then either contacting the E1A expressing tumor cell with a chemotherapeutic agent or irradiating the E1A-expressing tumor cell. The invention also provides methods of enhancing a subject's response to chemotherapy or irradiation by introducing into a subject's tumor cells nucleic acid encoding a polypeptide having adenovirus E1A activity, expressing the E1A active polypeptide in the cells and finally, administering either a chemotherapeutic agent or irradiation. The invention also provides a method of treating cancer.
    • 本发明涉及用腺病毒E1A敏化人肿瘤细胞的方法。 所述方法包括通过首先将编码具有腺病毒E1A活性的多肽的肿瘤细胞核酸引入细胞中表达E1A活性多肽,然后将表达E1A的肿瘤细胞与化学治疗剂接触或 照射表达E1A的肿瘤细胞。 本发明还提供了通过将受试者的肿瘤细胞核酸编码为具有腺病毒E1A活性的多肽,在细胞中表达E1A活性多肽,最后施用化学治疗剂或照射,来提供受试者对化疗或照射的反应的方法。 本发明还提供了一种治疗癌症的方法。